BD PharmingenTM PE-CyTM7 Mouse Anti-Human CD23

Description

Flow cytometric analysis of CD23 expression on human peripheral blood lymphocytes. Whole blood was stained with either PE-Cy7 Mouse Anti-Human CD23 antibody Cat. No. 561167; Left Panel or with a PE-Cy7 Mouse IgG1, kappa Isotype Control Cat. No. 557872; Right Panel and Alexa Fluor 700 Mouse anti-Human CD19 Cat. No. 557921 . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The two-color flow cytometric dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of CD23 expression on human peripheral blood lymphocytes. Whole blood was stained with either PE-Cy7 Mouse Anti-Human CD23 antibody Cat. No. 561167; Left Panel or with a PE-Cy7 Mouse IgG1, kappa Isotype Control Cat. No. 557872; Right Panel and Alexa Fluor 700 Mouse anti-Human CD19 Cat. No. 557921 . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The two-color flow cytometric dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of CD23 expression on human peripheral blood lymphocytes. Whole blood was stained with either PE-Cy7 Mouse Anti-Human CD23 antibody Cat. No. 561167; Left Panel or with a PE-Cy7 Mouse IgG1, kappa Isotype Control Cat. No. 557872; Right Panel and Alexa Fluor 700 Mouse anti-Human CD19 Cat. No. 557921 . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The two-color flow cytometric dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Show More Flow cytometric analysis of CD23 expression on human peripheral blood lymphocytes. Whole blood was stained with either PE-Cy7 Mouse Anti-Human CD23 antibody Cat. No. 561167; Left Panel or with a PE-Cy7 Mouse IgG1, kappa Isotype Control Cat. No. 557872; Right Panel and Alexa Fluor 700 Mouse anti-Human CD19 Cat. No. 557921 . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The two-color flow cytometric dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Show More Flow cytometric analysis of CD23 expression on human peripheral blood lymphocytes. Whole blood was stained with either PE-Cy7 Mouse Anti-Human CD23 antibody Cat. No. 561167; Left Panel or with a PE-Cy7 Mouse IgG1, kappa Isotype Control Cat. No. 557872; Right Panel and Alexa Fluor 700 Mouse anti-Human CD19 Cat. No. 557921 . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The two-color flow cytometric dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of CD23 expression on human peripheral blood lymphocytes. Whole blood was stained with either PE-Cy7 Mouse Anti-Human CD23 antibody Cat. No. 561167; Left Panel or with a PE-Cy7 Mouse IgG1, kappa Isotype Control Cat. No. 557872; Right Panel and Alexa Fluor 700 Mouse anti-Human CD19 Cat. No. 557921 . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The two-color flow cytometric dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD LSR II Flow Cytometer System.